Human CYP2C19 Gene Detection Kit Market Insights Video

According to Cognitive Market Research, the global Human CYP2C19 Gene Detection Kit market size was USD 99514.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 14.20% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 39805.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 29854.26 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 22888.27 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.2% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 4975.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 1990.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2031.
• The fastest-growing category in the Human CYP2C19 Gene Detection Kit market is Clinics. This growth is primarily attributed to the increasing trend of personalized healthcare and the rising number of outpatient services